> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-143/
- Published: 2017-08-06T12:00:00.000Z
- Updated: 2026-09-14T22:39:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139319

[**Guide on Child-Resistant Packaging Statements**](https://www.fdaweb.com/guide-on-child-resistant-packaging-statements/)  
*Federal Register* notice: FDA announces the availability of a draft guidance on “Child-Resistant Packaging Statements in Drug Product Labeling.” 08/03/2017

[**FDA Withdraws Approval for 4 B. Braun Medical Drugs**](https://www.fdaweb.com/fda-withdraws-approval-for-4-b-braun-medical-drugs/)  
*Federal Register* notice: FDA announces that it is withdrawing approval of three NDAs and one ANDA held by B. Braun Medical. 08/03/2017

[**FDA Webinar on OTC Monograph User Fees**](https://www.fdaweb.com/fda-webinar-on-otc-monograph-user-fees/)  
*Federal Register* notice: FDA announces an 8/23 Webinar to provide stakeholders with a status update on the process of FDA and industry discussions on an Over-the- Counter Monograph user fee program that began 7/2016\. 08/02/2017

[**Animal Drug User Fee Rates for 2018**](https://www.fdaweb.com/animal-drug-user-fee-rates-for-2018/)  
*Federal Register* notice: FDA announces the fee rates and payment procedures for fiscal year 2018 generic new animal drug user fees. 08/02/2017  
  
[**2018 User Fee Rates for Drug Compounders**](https://www.fdaweb.com/2018-user-fee-rates-for-drug-compounders/)  
*Federal Register* notice: FDA announces the fiscal year 2018 rates for the establishment and re-inspection fees related to entities that compound human drugs and elect to register as outsourcing facilities. 08/02/2017

[**User Fee Rates for Animal Drugs**](https://www.fdaweb.com/user-fee-rates-for-animal-drugs/)  
*Federal Register* notice: FDA announces the rates and payment procedures for fiscal year 2018 animal drug user fees. 08/02/2017

[**Comments Sought on De Novo Device Submissions**](https://www.fdaweb.com/comments-sought-on-de-novo-device-submissions/)  
*Federal Register* notice: FDA seeks comments on a new information collection for “De Novo Classification Process (Evaluation of Automatic Class 3 Designation).” 08/02/2017

[**FDA Puts Oral Palatal Space Occupying Device Into Class 2**](https://www.fdaweb.com/fda-puts-oral-palatal-space-occupying-device-into-class-2/)  
*Federal Register* notice: FDA classifies as a Class 2 (special controls) medical device the oral removable palatal space occupying device for weight management or weight loss. 07/31/2017